Giorgia Guglielmi
Giorgia Guglielmi is a freelance science writer based in Basel, Switzerland. Specializing in life sciences, medicine, and the relationship between science and society, she has published numerous articles in outlets including Nature, Science, and Scientific American. She holds a PhD in biology from the European Molecular Biology Laboratory and a Master’s in Science Writing from the Massachusetts Institute of Technology. She has received recognition for her work, including the John Kendrew Award in 2020 and an ERC-funded FRONTIERS Media Fellowship in 2025. She has also led lectures and workshops on science communication at institutions such as Harvard University and the University of Zurich.
Controlling cadaverine levels and the gut bacteria that produce it could help regulate immune cell metabolism and inflammation.
Environments and social factors shape human microbiotas.
The abundance of Bifidobacterium may explain M116’s excellent cholesterol profile and low inflammation levels.
The authors propose a coordinated framework involving policymakers, scientists, educators, and communities to embed microbiota science into One Health strategies.
Targeting gut bacteria or butyrate could be a promising therapy for glioma.
Dietary fiber during early life protects fertility by supporting healthy gut microbes and preventing ovarian damage caused by high-fat diets.
Gut microbes could be a target for preventing kidney disease-related heart failure.
Restoring beneficial bacteria could lead to new treatments for chronic pain in people with sickle cell disease.
Gut microbes can interact with genetics and hormone metabolism to influence pregnancy outcomes.
Combining data about gut-brain–related disorders with genetic and other information provides a powerful approach for predicting Alzheimer’s and Parkinson’s disease.
